Mobeck Kenneth S.
Transaction: 05/12/2026
BUY
Change
+144,141
Price
$4.17
Filing
05/13/2026
Type
BUY
Edap Tms S.a.
EDAP • Medical - Specialties
$4.75
▼ -0.03 (-0.52%)
Current price
EarningsLatest report: Mar 31, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$178.23M
Growth
-3.4%
Cash Flow
1/5
Trend
Volatile
Evidence
Positive revenue growth · 8.3%Healthy liquidity · 1.54Weak profitability
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.76
Change-0.52%
Shares Out37.48M
Market Cap$178.23M
Enterprise Value$165.56M
52W Range1.21 - 5.05
Beta-0.08
P/E-5.94
P/S2.48
P/B17.64
P/FCF-9.57
EV/Sales2.30
Price$4.76
Change-0.52%
Shares Out37.48M
Market Cap$178.23M
Enterprise Value$165.56M
52W Range1.21 - 5.05
Beta-0.08
P/E-5.94
P/S2.48
P/B17.64
P/FCF-9.57
EV/Sales2.30
EV/EBITDA-7.08
EV/FCF-8.89
Earnings Yield-16.85%
FCF Yield-10.44%
Dividend Yield0.00%
Gross Margin42.54%
Oper. Margin-35.63%
Profit Margin-41.47%
Debt/Eq1.43
Current Ratio1.54
Quick Ratio1.25
Revenue 5Y-3.35%
Target$10.00
Target Upside110.30%
Target Median$10.00
Target Range10.00 - 10.00
Volume28.86K
Avg Volume39.24K
EPS Surprise-0.02
Investment DNA
How strong this company looks for long-term investors
49
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
57/100
Growth Potential
Revenue and expansion
87/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Positive revenue growth · 8.3%Healthy liquidity · 1.54Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 8 analyst votes · 2026-10-21
81/100
Bullish
Bullish
5
Hold
3
Bearish
0
Price Target
2026-06-29
Low
$10.00
Mean
$10.00
Median
$10.00
High
$10.00
Insider Transactions
Recent executive and insider activity
Mobeck Kenneth S.
Transaction: 05/12/2026
BUY
Change
+120,000
Price
Not reported
Filing
05/13/2026
Type
BUY
WILLSEY LANCE
Transaction: 05/12/2026
BUY
Change
+114,285
Price
$4.17
Filing
05/13/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mobeck Kenneth S. | BUY | +144,141 | $4.17 | 05/12/2026 | 05/13/2026 |
| Mobeck Kenneth S. | BUY | +120,000 | Not reported | 05/12/2026 | 05/13/2026 |
| WILLSEY LANCE | BUY | +114,285 | $4.17 | 05/12/2026 | 05/13/2026 |
| Rhodes Ryan | BUY | +390,000 | $4.17 | 05/12/2026 | 05/13/2026 |
| Rhodes Ryan | BUY | +304,500 | Not reported | 05/12/2026 | 05/13/2026 |
| Shah Sanket | BUY | +67,500 | Not reported | 05/12/2026 | 05/13/2026 |
| Shah Sanket | BUY | +75,000 | $4.17 | 05/12/2026 | 05/13/2026 |
| Annen Steven | BUY | +100,000 | $4.17 | 05/12/2026 | 05/13/2026 |
| Annen Steven | BUY | +90,000 | Not reported | 05/12/2026 | 05/13/2026 |
| LEVINE JOSHUA | BUY | +10,000 | $4.22 | 05/11/2026 | 05/13/2026 |
| Horn David R. | OTHER | 0 | Not reported | 02/11/2026 | 02/13/2026 |
| WILLSEY LANCE | OTHER | +280,000 | $1.42 | 01/01/2026 | 01/14/2026 |
| WILLSEY LANCE | OTHER | 0 | Not reported | 01/01/2026 | 01/14/2026 |
| Rhodes Ryan | OTHER | +800,000 | $6.57 | 01/01/2026 | 01/14/2026 |
| Rhodes Ryan | OTHER | 0 | Not reported | 01/01/2026 | 01/14/2026 |
| Annen Steven | OTHER | +123,750 | $1.74 | 01/01/2026 | 01/14/2026 |
| Annen Steven | OTHER | 0 | Not reported | 01/01/2026 | 01/14/2026 |
| Dietsch Francois Mattieu | OTHER | +10,000 | $3.11 | 01/01/2026 | 01/13/2026 |
| Dietsch Francois Mattieu | OTHER | 0 | Not reported | 01/01/2026 | 01/13/2026 |
| Mobeck Kenneth S. | OTHER | +375,000 | $11.68 | 01/01/2026 | 01/13/2026 |